Publicación:
The reduction of the expression of B-catenin and c-Myc is related to a better outcome in patients with AML

Vista sencilla de ítem
dc.contributor.authorCardona A.
dc.contributor.authorPrada-Arismendy J.
dc.contributor.authorCastillo E.
dc.contributor.authorArroyave J.C.
dc.date.accessioned2020-08-28T22:27:46Z
dc.date.available2020-08-28T22:27:46Z
dc.date.issued2018
dc.identifier.doi10.1093/annonc/mdy314.018
dc.identifier.urihttps://hdl.handle.net/20.500.12622/3284
dc.relation.citationstartpagevi26
dc.relation.citationvolume29
dc.rights.accessrightsinfo:eu-repo/semantics/closedAccess
dc.sourceScopus
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85081679830&doi=10.1093%2fannonc%2fmdy314.018&partnerID=40&md5=44ddcabc2809c0d050f6217d185b73a5
dc.titleThe reduction of the expression of B-catenin and c-Myc is related to a better outcome in patients with AMLspa
dc.title.alternativeAnnals of oncology : official journal of the European Society for Medical Oncology
dc.typeinfo:eu-repo/semantics/article
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dspace.entity.typePublication

Archivos

Colecciones

Artículos de Investigación Indexados